Our lab also showed that when we deliver native α-CGRP through osmotic mini-pumps for 28 days to the TAC-WT mice, CGRP administration is cardio-protective against pressure-overload induced heart failure (Kumar et al., 2019b). The gene discussed is CALCA; the disease is persistent truncus arteriosus.